FDA Approves Over-the-Counter Naloxone Product for Opioid Overdose Reversal

The U.S. FDA has granted over-the-counter approval for Rextovy, a 4 mg intranasal naloxone product. This decision significantly broadens public access to a crucial medication used to reverse opioid overdoses, potentially saving more lives.